Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis
Thomas Leist, S. D. Cook, Gıancarlo Comı, Xavier Montalbán, Gavin Giovannoni, Axel Nolting, Doris Damian, S. Syed, Andrew Galazka
Topics & Concepts
CladribineMedicineAdverse effectInternal medicinePlaceboIncidence (geometry)CohortMultiple sclerosisPopulationClinical trialImmunologyPathologyOpticsAlternative medicinePhysicsEnvironmental healthMultiple Sclerosis Research StudiesMultiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research